SI20642A - Nova karbonil-reduktaza, gen le-te in postopek za uporabo le-teh - Google Patents

Nova karbonil-reduktaza, gen le-te in postopek za uporabo le-teh Download PDF

Info

Publication number: SI20642A
Authority: SI; Slovenia
Prior art keywords: butyl; tert; chloro; polypeptide; expression vector
Prior art date: 1999-12-03

Application number

SI200020017A

Other languages

English (en)

Slovenian (sl)

Inventor

Noriyuki Kizaki

Yukio Yamada

Yoshihiko Yasohara

Junzo Hasegawa

Original Assignee

Kaneka Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-03

Filing date

2000-11-24

Publication date

2002-02-28

2000-11-24 Application filed by Kaneka Corporation filed Critical Kaneka Corporation

2002-02-28 Publication of SI20642A publication Critical patent/SI20642A/sl

Links

238000000034 method Methods 0.000 title claims description 47
108090000623 proteins and genes Proteins 0.000 title description 23
102000005751 Alcohol Oxidoreductases Human genes 0.000 title description 2
108010031132 Alcohol Oxidoreductases Proteins 0.000 title description 2
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 74
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 70
229920001184 polypeptide Polymers 0.000 claims abstract description 69
108091033319 polynucleotide Proteins 0.000 claims abstract description 50
102000040430 polynucleotide Human genes 0.000 claims abstract description 50
239000002157 polynucleotide Substances 0.000 claims abstract description 50
125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 30
230000002255 enzymatic effect Effects 0.000 claims abstract description 17
238000007792 addition Methods 0.000 claims abstract description 7
238000006467 substitution reaction Methods 0.000 claims abstract description 7
238000003780 insertion Methods 0.000 claims abstract description 5
230000037431 insertion Effects 0.000 claims abstract description 5
238000012217 deletion Methods 0.000 claims abstract description 4
230000037430 deletion Effects 0.000 claims abstract description 4
244000005700 microbiome Species 0.000 claims description 46
239000002773 nucleotide Substances 0.000 claims description 45
125000003729 nucleotide group Chemical group 0.000 claims description 45
POXZJNFSZVURGY-BDAKNGLRSA-N butyl (3r,5s)-6-chloro-3,5-dihydroxyhexanoate Chemical compound CCCCOC(=O)C[C@H](O)C[C@H](O)CCl POXZJNFSZVURGY-BDAKNGLRSA-N 0.000 claims description 43
230000000694 effects Effects 0.000 claims description 33
UXNDSXNDEPGLAY-VIFPVBQESA-N butyl (5s)-6-chloro-5-hydroxy-3-oxohexanoate Chemical compound CCCCOC(=O)CC(=O)C[C@H](O)CCl UXNDSXNDEPGLAY-VIFPVBQESA-N 0.000 claims description 32
238000006243 chemical reaction Methods 0.000 claims description 25
239000013612 plasmid Substances 0.000 claims description 24
108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 21
239000013604 expression vector Substances 0.000 claims description 18
241001131785 Escherichia coli HB101 Species 0.000 claims description 16
239000005515 coenzyme Substances 0.000 claims description 16
241000588724 Escherichia coli Species 0.000 claims description 14
241000222292 [Candida] magnoliae Species 0.000 claims description 14
238000004519 manufacturing process Methods 0.000 claims description 12
241000222120 Candida <Saccharomycetales> Species 0.000 claims description 4
238000011084 recovery Methods 0.000 claims description 4
230000001131 transforming effect Effects 0.000 claims description 4
241000194107 Bacillus megaterium Species 0.000 claims description 3
FIKPWJZUGTVXCO-SFYZADRCSA-N tert-butyl (3r,5s)-6-chloro-3,5-dihydroxyhexanoate Chemical compound CC(C)(C)OC(=O)C[C@H](O)C[C@H](O)CCl FIKPWJZUGTVXCO-SFYZADRCSA-N 0.000 abstract description 4
WLRFCPQXWBDLRG-QMMMGPOBSA-N tert-butyl (5s)-6-chloro-5-hydroxy-3-oxohexanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C[C@H](O)CCl WLRFCPQXWBDLRG-QMMMGPOBSA-N 0.000 abstract description 3
150000001413 amino acids Chemical class 0.000 abstract description 2
108090000790 Enzymes Proteins 0.000 description 53
102000004190 Enzymes Human genes 0.000 description 42
108020004414 DNA Proteins 0.000 description 24
239000012634 fragment Substances 0.000 description 22
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 17
239000013615 primer Substances 0.000 description 15
239000013598 vector Substances 0.000 description 15
239000000284 extract Substances 0.000 description 14
239000000243 solution Substances 0.000 description 14
210000004027 cell Anatomy 0.000 description 13
239000008363 phosphate buffer Substances 0.000 description 13
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 12
239000013611 chromosomal DNA Substances 0.000 description 12
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
108010029645 galactitol 2-dehydrogenase Proteins 0.000 description 9
238000009396 hybridization Methods 0.000 description 9
239000002609 medium Substances 0.000 description 9
239000000047 product Substances 0.000 description 9
102100031126 6-phosphogluconolactonase Human genes 0.000 description 8
108010000445 Glycerate dehydrogenase Proteins 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
239000000523 sample Substances 0.000 description 8
239000000758 substrate Substances 0.000 description 8
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 7
229910052921 ammonium sulfate Inorganic materials 0.000 description 7
235000011130 ammonium sulphate Nutrition 0.000 description 7
239000008103 glucose Substances 0.000 description 7
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
108091028043 Nucleic acid sequence Proteins 0.000 description 6
108020005038 Terminator Codon Proteins 0.000 description 6
239000000872 buffer Substances 0.000 description 6
238000001514 detection method Methods 0.000 description 6
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
238000004440 column chromatography Methods 0.000 description 5
102000053602 DNA Human genes 0.000 description 4
240000004808 Saccharomyces cerevisiae Species 0.000 description 4
229920002684 Sepharose Polymers 0.000 description 4
108091081024 Start codon Proteins 0.000 description 4
238000010521 absorption reaction Methods 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
238000002372 labelling Methods 0.000 description 4
238000001556 precipitation Methods 0.000 description 4
108091008146 restriction endonucleases Proteins 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
239000002904 solvent Substances 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
229940041514 candida albicans extract Drugs 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
238000000605 extraction Methods 0.000 description 3
238000011141 high resolution liquid chromatography Methods 0.000 description 3
239000000463 material Substances 0.000 description 3
239000000203 mixture Substances 0.000 description 3
239000002244 precipitate Substances 0.000 description 3
238000012163 sequencing technique Methods 0.000 description 3
239000012138 yeast extract Substances 0.000 description 3
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
108020001019 DNA Primers Proteins 0.000 description 2
239000003155 DNA primer Substances 0.000 description 2
108010053229 Lysyl endopeptidase Proteins 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
102000007079 Peptide Fragments Human genes 0.000 description 2
108010033276 Peptide Fragments Proteins 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
238000000246 agarose gel electrophoresis Methods 0.000 description 2
235000011114 ammonium hydroxide Nutrition 0.000 description 2
238000010923 batch production Methods 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
238000010586 diagram Methods 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
239000003623 enhancer Substances 0.000 description 2
101150019455 gdh gene Proteins 0.000 description 2
238000002955 isolation Methods 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000009630 liquid culture Methods 0.000 description 2
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
238000005259 measurement Methods 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
239000000575 pesticide Substances 0.000 description 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
239000013600 plasmid vector Substances 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
238000011002 quantification Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
ALBODLTZUXKBGZ-JUUVMNCLSA-N (2s)-2-amino-3-phenylpropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 ALBODLTZUXKBGZ-JUUVMNCLSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
241000590020 Achromobacter Species 0.000 description 1
HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 1
DPNZTBKGAUAZQU-DLOVCJGASA-N Ala-Leu-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N DPNZTBKGAUAZQU-DLOVCJGASA-N 0.000 description 1
ADSGHMXEAZJJNF-DCAQKATOSA-N Ala-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N ADSGHMXEAZJJNF-DCAQKATOSA-N 0.000 description 1
108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 1
GOWZVQXTHUCNSQ-NHCYSSNCSA-N Arg-Glu-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O GOWZVQXTHUCNSQ-NHCYSSNCSA-N 0.000 description 1
RFXXUWGNVRJTNQ-QXEWZRGKSA-N Arg-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N RFXXUWGNVRJTNQ-QXEWZRGKSA-N 0.000 description 1
HZPSDHRYYIORKR-WHFBIAKZSA-N Asn-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O HZPSDHRYYIORKR-WHFBIAKZSA-N 0.000 description 1
XYOVHPDDWCEUDY-CIUDSAMLSA-N Asn-Ala-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O XYOVHPDDWCEUDY-CIUDSAMLSA-N 0.000 description 1
GQRDIVQPSMPQME-ZPFDUUQYSA-N Asn-Ile-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O GQRDIVQPSMPQME-ZPFDUUQYSA-N 0.000 description 1
CBWCQCANJSGUOH-ZKWXMUAHSA-N Asn-Val-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O CBWCQCANJSGUOH-ZKWXMUAHSA-N 0.000 description 1
GWTLRDMPMJCNMH-WHFBIAKZSA-N Asp-Asn-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GWTLRDMPMJCNMH-WHFBIAKZSA-N 0.000 description 1
LKIYSIYBKYLKPU-BIIVOSGPSA-N Asp-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O LKIYSIYBKYLKPU-BIIVOSGPSA-N 0.000 description 1
JHFNSBBHKSZXKB-VKHMYHEASA-N Asp-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(O)=O JHFNSBBHKSZXKB-VKHMYHEASA-N 0.000 description 1
PSLSTUMPZILTAH-BYULHYEWSA-N Asp-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O PSLSTUMPZILTAH-BYULHYEWSA-N 0.000 description 1
LKVKODXGSAFOFY-VEVYYDQMSA-N Asp-Met-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LKVKODXGSAFOFY-VEVYYDQMSA-N 0.000 description 1
LTCKTLYKRMCFOC-KKUMJFAQSA-N Asp-Phe-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O LTCKTLYKRMCFOC-KKUMJFAQSA-N 0.000 description 1
PDIYGFYAMZZFCW-JIOCBJNQSA-N Asp-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N)O PDIYGFYAMZZFCW-JIOCBJNQSA-N 0.000 description 1
USENATHVGFXRNO-SRVKXCTJSA-N Asp-Tyr-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=C(O)C=C1 USENATHVGFXRNO-SRVKXCTJSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
108020003215 DNA Probes Proteins 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
108010059378 Endopeptidases Proteins 0.000 description 1
102000005593 Endopeptidases Human genes 0.000 description 1
108090000698 Formate Dehydrogenases Proteins 0.000 description 1
WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
MPZWMIIOPAPAKE-BQBZGAKWSA-N Glu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N MPZWMIIOPAPAKE-BQBZGAKWSA-N 0.000 description 1
CKRUHITYRFNUKW-WDSKDSINSA-N Glu-Asn-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CKRUHITYRFNUKW-WDSKDSINSA-N 0.000 description 1
ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 1
FMBWLLMUPXTXFC-SDDRHHMPSA-N Glu-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)N)C(=O)O FMBWLLMUPXTXFC-SDDRHHMPSA-N 0.000 description 1
ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 1
108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
102000002794 Glucosephosphate Dehydrogenase Human genes 0.000 description 1
PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 1
SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 1
YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 1
JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
108010020056 Hydrogenase Proteins 0.000 description 1
APDIECQNNDGFPD-PYJNHQTQSA-N Ile-His-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C(C)C)C(=O)O)N APDIECQNNDGFPD-PYJNHQTQSA-N 0.000 description 1
PARSHQDZROHERM-NHCYSSNCSA-N Ile-Lys-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)N PARSHQDZROHERM-NHCYSSNCSA-N 0.000 description 1
XLXPYSDGMXTTNQ-DKIMLUQUSA-N Ile-Phe-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(O)=O XLXPYSDGMXTTNQ-DKIMLUQUSA-N 0.000 description 1
XLXPYSDGMXTTNQ-UHFFFAOYSA-N Ile-Phe-Leu Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 XLXPYSDGMXTTNQ-UHFFFAOYSA-N 0.000 description 1
YBKKLDBBPFIXBQ-MBLNEYKQSA-N Ile-Thr-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O)N YBKKLDBBPFIXBQ-MBLNEYKQSA-N 0.000 description 1
RWHRUZORDWZESH-ZQINRCPSSA-N Ile-Trp-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RWHRUZORDWZESH-ZQINRCPSSA-N 0.000 description 1
FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
KWTVLKBOQATPHJ-SRVKXCTJSA-N Leu-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N KWTVLKBOQATPHJ-SRVKXCTJSA-N 0.000 description 1
ULXYQAJWJGLCNR-YUMQZZPRSA-N Leu-Asp-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O ULXYQAJWJGLCNR-YUMQZZPRSA-N 0.000 description 1
DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 1
LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 1
DAYQSYGBCUKVKT-VOAKCMCISA-N Leu-Thr-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DAYQSYGBCUKVKT-VOAKCMCISA-N 0.000 description 1
XFIHDSBIPWEYJJ-YUMQZZPRSA-N Lys-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN XFIHDSBIPWEYJJ-YUMQZZPRSA-N 0.000 description 1
PRCHKVGXZVTALR-KKUMJFAQSA-N Lys-His-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCCCN)N PRCHKVGXZVTALR-KKUMJFAQSA-N 0.000 description 1
MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 1
NJNRBRKHOWSGMN-SRVKXCTJSA-N Lys-Leu-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O NJNRBRKHOWSGMN-SRVKXCTJSA-N 0.000 description 1
YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
ZKSLXIGKRJMALF-MGHWNKPDSA-N Phe-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CC=CC=C2)N ZKSLXIGKRJMALF-MGHWNKPDSA-N 0.000 description 1
LHALYDBUDCWMDY-CIUDSAMLSA-N Pro-Glu-Ala Chemical compound C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O LHALYDBUDCWMDY-CIUDSAMLSA-N 0.000 description 1
FFSLAIOXRMOFIZ-GJZGRUSLSA-N Pro-Gly-Trp Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)CNC(=O)[C@@H]1CCCN1 FFSLAIOXRMOFIZ-GJZGRUSLSA-N 0.000 description 1
IBGCFJDLCYTKPW-NAKRPEOUSA-N Pro-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 IBGCFJDLCYTKPW-NAKRPEOUSA-N 0.000 description 1
RVQDZELMXZRSSI-IUCAKERBSA-N Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 RVQDZELMXZRSSI-IUCAKERBSA-N 0.000 description 1
KIDXAAQVMNLJFQ-KZVJFYERSA-N Pro-Thr-Ala Chemical compound C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(O)=O KIDXAAQVMNLJFQ-KZVJFYERSA-N 0.000 description 1
FHJQROWZEJFZPO-SRVKXCTJSA-N Pro-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 FHJQROWZEJFZPO-SRVKXCTJSA-N 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
101150056072 TUFB gene Proteins 0.000 description 1
PXQUBKWZENPDGE-CIQUZCHMSA-N Thr-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)N PXQUBKWZENPDGE-CIQUZCHMSA-N 0.000 description 1
XSLXHSYIVPGEER-KZVJFYERSA-N Thr-Ala-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O XSLXHSYIVPGEER-KZVJFYERSA-N 0.000 description 1
GNHRVXYZKWSJTF-HJGDQZAQSA-N Thr-Asp-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O GNHRVXYZKWSJTF-HJGDQZAQSA-N 0.000 description 1
JWQNAFHCXKVZKZ-UVOCVTCTSA-N Thr-Lys-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JWQNAFHCXKVZKZ-UVOCVTCTSA-N 0.000 description 1
DEGCBBCMYWNJNA-RHYQMDGZSA-N Thr-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O DEGCBBCMYWNJNA-RHYQMDGZSA-N 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
PITVQFJBUFDJDD-XEGUGMAKSA-N Trp-Ile Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O)=CNC2=C1 PITVQFJBUFDJDD-XEGUGMAKSA-N 0.000 description 1
XGJLNBNZNMVJRS-NRPADANISA-N Val-Glu-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O XGJLNBNZNMVJRS-NRPADANISA-N 0.000 description 1
KNYHAWKHFQRYOX-PYJNHQTQSA-N Val-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N KNYHAWKHFQRYOX-PYJNHQTQSA-N 0.000 description 1
GVRKWABULJAONN-VQVTYTSYSA-N Val-Thr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GVRKWABULJAONN-VQVTYTSYSA-N 0.000 description 1
YQYFYUSYEDNLSD-YEPSODPASA-N Val-Thr-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O YQYFYUSYEDNLSD-YEPSODPASA-N 0.000 description 1
XNLUVJPMPAZHCY-JYJNAYRXSA-N Val-Val-Phe Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 XNLUVJPMPAZHCY-JYJNAYRXSA-N 0.000 description 1
238000005273 aeration Methods 0.000 description 1
108010041407 alanylaspartic acid Proteins 0.000 description 1
108010005233 alanylglutamic acid Proteins 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
108010047857 aspartylglycine Proteins 0.000 description 1
239000012267 brine Substances 0.000 description 1
-1 butyl (S) -6-chloro-5-hydroxy-3-oxohexanoate Chemical compound 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
238000010367 cloning Methods 0.000 description 1
238000010924 continuous production Methods 0.000 description 1
239000013601 cosmid vector Substances 0.000 description 1
239000000287 crude extract Substances 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
238000012258 culturing Methods 0.000 description 1
230000006837 decompression Effects 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
238000010612 desalination reaction Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
FESAXEDIWWXCNG-UHFFFAOYSA-N diethyl(methoxy)borane Chemical compound CCB(CC)OC FESAXEDIWWXCNG-UHFFFAOYSA-N 0.000 description 1
230000010339 dilation Effects 0.000 description 1
DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
108010050848 glycylleucine Proteins 0.000 description 1
108010087823 glycyltyrosine Proteins 0.000 description 1
108010037850 glycylvaline Proteins 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
108010036413 histidylglycine Proteins 0.000 description 1
108010085325 histidylproline Proteins 0.000 description 1
239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
108010030617 leucyl-phenylalanyl-valine Proteins 0.000 description 1
108010057821 leucylproline Proteins 0.000 description 1
239000011707 mineral Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
108010073101 phenylalanylleucine Proteins 0.000 description 1
229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 description 1
238000012545 processing Methods 0.000 description 1
108010015796 prolylisoleucine Proteins 0.000 description 1
238000000746 purification Methods 0.000 description 1
101150079601 recA gene Proteins 0.000 description 1
238000004366 reverse phase liquid chromatography Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000000926 separation method Methods 0.000 description 1
229910000033 sodium borohydride Inorganic materials 0.000 description 1
239000012279 sodium borohydride Substances 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000008399 tap water Substances 0.000 description 1
235000020679 tap water Nutrition 0.000 description 1
238000009210 therapy by ultrasound Methods 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
101150099542 tuf gene Proteins 0.000 description 1
101150071165 tuf1 gene Proteins 0.000 description 1
101150010742 tuf2 gene Proteins 0.000 description 1
238000000108 ultra-filtration Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/002—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Analytical Chemistry (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Mycology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Enzymes And Modification Thereof (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Saccharide Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

SI200020017A 1999-12-03 2000-11-24 Nova karbonil-reduktaza, gen le-te in postopek za uporabo le-teh SI20642A (sl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP34554199		1999-12-03
PCT/JP2000/008321 WO2001040450A1 (en)	1999-12-03	2000-11-24	Novel carbonyl reductase, gene thereof and method of using the same

Publications (1)

Publication Number	Publication Date
SI20642A true SI20642A (sl)	2002-02-28

Family

ID=18377296

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200020017A SI20642A (sl)	1999-12-03	2000-11-24	Nova karbonil-reduktaza, gen le-te in postopek za uporabo le-teh

Country Status (15)

Country	Link
US (1)	US6645746B1 (ja)
EP (1)	EP1152054B1 (ja)
JP (1)	JP4510351B2 (ja)
KR (1)	KR100512080B1 (ja)
AT (1)	ATE291616T1 (ja)
AU (1)	AU1551701A (ja)
CA (1)	CA2360376C (ja)
CZ (1)	CZ20012792A3 (ja)
DE (1)	DE60018909T2 (ja)
ES (1)	ES2240205T3 (ja)
HU (1)	HUP0105331A3 (ja)
MX (1)	MXPA01007858A (ja)
NO (1)	NO20013801L (ja)
SI (1)	SI20642A (ja)
WO (1)	WO2001040450A1 (ja)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1537222B1 (en) *	2002-08-09	2011-03-09	Codexis, Inc.	Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives
AU2003289229A1 (en) *	2002-12-06	2004-06-30	Kaneka Corporation	Process for producing optically active 3-hydroxypropionic ester derivative
WO2005017135A1 (en) *	2003-08-11	2005-02-24	Codexis, Inc.	Improved ketoreductase polypeptides and related polynucleotides
US7588928B2 (en) *	2003-08-11	2009-09-15	Codexis, Inc.	Halohydrin dehalogenases and related polynucleotides
US7824898B2 (en)	2003-08-11	2010-11-02	Codexis, Inc.	Halohydrin dehalogenases and related polynucleotides
KR20060071397A (ko) *	2003-08-11	2006-06-26	코덱시스, 인코포레이티드	4-치환된 3-히드록시부티르산 유도체 및 이웃자리 시아노,히드록시 치환된 카르복실산 에스테르의 효소적 제조 방법
US7816111B2 (en) *	2003-08-11	2010-10-19	Codexis, Inc.	Glucose dehydrogenase polypeptides and related polynucleotides
US7541171B2 (en) *	2003-08-11	2009-06-02	Codexis, Inc.	Halohydrin dehalogenases and related polynucleotides
DE10345772A1 (de) *	2003-10-01	2005-04-21	Basf Ag	Verfahren zur Herstellung von 3-Methylamino-1-(thien-2-yl)-propan-1-ol
US8008461B2 (en)	2004-10-27	2011-08-30	Kaneka Corporation	Carbonyl reductase, gene therefor and use thereof
DE102005044736A1 (de) *	2005-09-19	2007-03-22	Basf Ag	Neue Dehydrogenasen, deren Derivate und ein Verfahren zur Herstellung von optisch aktiven Alkanolen
AT503017B1 (de) *	2005-12-19	2007-07-15	Iep Gmbh	Verfahren zur enantioselektiven enzymatischen reduktion von hydroxyketoverbindungen
US8304216B2 (en)	2006-03-31	2012-11-06	Kaneka Corporation	Method for production of erythro-or threo-2-amino-3-hydroxypropionic acid ester, novel carbonyl reductase, gene for the reductase, vector, transformant, and method for production of optically active alcohol using those
US7879585B2 (en)	2006-10-02	2011-02-01	Codexis, Inc.	Ketoreductase enzymes and uses thereof
AT504542B1 (de) *	2006-12-07	2008-09-15	Iep Gmbh	Verfahren zur enantioselektiven enzymatischen reduktion von secodionderivaten
US7820421B2 (en)	2007-02-08	2010-10-26	Codexis, Inc.	Ketoreductases and uses thereof
US7977078B2 (en)	2007-08-24	2011-07-12	Codexis, Inc.	Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane
KR101586503B1 (ko)	2007-09-13	2016-01-18	코덱시스, 인코포레이티드	아세토페논의 환원을 위한 케토리덕타제 폴리펩티드
TWI601825B (zh) *	2007-09-27	2017-10-11	Ｉｅｐ有限公司	對映異構選擇性酶催化還原中間產物之方法
WO2009042984A1 (en)	2007-09-28	2009-04-02	Codexis, Inc.	Ketoreductase polypeptides and uses thereof
EP2205727B1 (en)	2007-10-01	2015-06-24	Codexis, Inc.	Ketoreductase polypeptides for the production of azetidinone
SI2329013T1 (sl)	2008-08-27	2016-03-31	Codexis, Inc.	Polipeptidi ketoreduktaze za proizvodnjo 3-aril-3-hidroksipropanamina iz 3-aril-3-ketopropanamina
WO2010027710A2 (en)	2008-08-27	2010-03-11	Codexis, Inc.	Ketoreductase polypeptides and uses thereof
WO2010025287A2 (en)	2008-08-27	2010-03-04	Codexis, Inc.	Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
EP2329014B1 (en)	2008-08-29	2014-10-22	Codexis, Inc.	Ketoreductase polypeptides for the stereoselective production of (4s)-3[(5s)-5(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one
US8187856B2 (en)	2008-12-18	2012-05-29	Codexis, Inc.	Recombinant halohydrin dehalogenase polypeptides
EP2226386A1 (de)	2009-03-05	2010-09-08	IEP GmbH	Verfahren zur stereoselektiven enzymatischen Reduktion von Ketoverbindungen
US8501436B2 (en) *	2009-06-22	2013-08-06	Sk Biopharmaceuticals Co. Ltd.	Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
WO2011005527A2 (en)	2009-06-22	2011-01-13	Codexis, Inc.	Ketoreductase-mediated stereoselective route to alpha chloroalcohols
SG10201405022PA (en)	2009-08-19	2014-10-30	Codexis Inc	Ketoreductase polypeptides for the preparation of phenylephrine
US8404461B2 (en)	2009-10-15	2013-03-26	SK Biopharmaceutical Co. Ltd.	Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
WO2011100265A2 (en)	2010-02-10	2011-08-18	Codexis, Inc.	Processes using amino acid dehydrogenases and ketoreductase-based cofactor regenerating system
WO2011140219A1 (en)	2010-05-04	2011-11-10	Codexis, Inc.	Biocatalysts for ezetimibe synthesis
JP5941410B2 (ja)	2010-11-09	2016-06-29	株式会社カネカ	ハロゲン化インデノン類及びそれを用いた光学活性インダノン類又は光学活性インダノール類の製造方法
CN102676596A (zh) *	2011-03-16	2012-09-19	苏州国镝医药科技有限公司	生物酶手性合成立普妥中间体ats-7
IN2014CN04470A (ja)	2011-11-18	2015-09-04	Codexis Inc
TW201343623A (zh)	2012-02-07	2013-11-01	Annikki Gmbh	使氧化還原輔因子經酶催化再生之方法
US9902981B2 (en)	2012-02-07	2018-02-27	Annikki Gmbh	Process for the production of furan derivatives from glucose
WO2013117251A1 (de)	2012-02-07	2013-08-15	Annikki Gmbh	Verfahren zur enzymatischen regenerierung von redoxkofaktoren
DE102012017026A1 (de)	2012-08-28	2014-03-06	Forschungszentrum Jülich GmbH	Sensor für NADP(H) und Entwicklung von Alkoholdehydrogenasen
KR101446551B1 (ko)	2013-02-26	2014-10-06	주식회사 아미노로직스	(2rs)-아미노-(3s)-히드록시-부티르산 또는 이의 유도체의 제조방법
US10253340B2 (en)	2013-03-27	2019-04-09	Annikki Gmbh	Method for the isomerisation of glucose
CN121203988A (zh)	2014-04-22	2025-12-26	C-乐克塔股份有限公司	酮还原酶
CN104328148A (zh) *	2014-11-04	2015-02-04	尚科生物医药（上海）有限公司	酶法制备(3r,5s)-6-氯-3,5-二羟基己酸叔丁酯
ES2830725T3 (es)	2015-02-10	2021-06-04	Codexis Inc	Polipéptidos cetoreductasa para la síntesis de compuestos quirales
CN104830921B (zh) *	2015-04-27	2019-07-02	上海工业生物技术研发中心	一种酶法制备他汀类化合物中间体的方法
CN105087685A (zh) *	2015-09-16	2015-11-25	连云港宏业化工有限公司	一种合成（3r，5s）-6-氯-3,5-二羟基己酸叔丁酯的方法
CN105087684A (zh) *	2015-09-16	2015-11-25	连云港宏业化工有限公司	一种（3r，5s）-6-氯-3,5-二羟基己酸叔丁酯的制备方法
CN106011092A (zh) *	2016-06-20	2016-10-12	苏州汉酶生物技术有限公司	一种工程化酮还原酶多肽及其用于制备孟鲁斯特中间体的方法
CN106011095B (zh) *	2016-07-27	2021-02-26	苏州汉酶生物技术有限公司	工程化酮还原酶多肽及使用其制备依替米贝中间体的方法
JP7045725B2 (ja)	2017-04-27	2022-04-01	コデクシス，インコーポレイテッド	ケトレダクターゼポリペプチドおよびポリヌクレオチド
WO2019012095A1 (en)	2017-07-14	2019-01-17	C-Lecta Gmbh	TCO-reductase
CN108441523A (zh) *	2018-03-22	2018-08-24	南京工业大学	（3r,5s）-6-氯-3,5,-二羟基己酸叔丁酯的制备方法
CN110387359B (zh) *	2018-04-17	2021-04-20	湖州颐盛生物科技有限公司	羰基还原酶突变体及其应用
EP3587393B1 (en)	2018-06-21	2024-01-17	F.I.S.- Fabbrica Italiana Sintetici S.p.A.	Enzymatic process for the preparation of droxidopa
BR112023020229A2 (pt)	2021-04-02	2023-11-14	Hoffmann La Roche	Processos para a preparação de um composto bicíclico de cetona quiral, composto de n-amino lactama quiral, composto de sal imidato e composto hidroxicetoéster, composto, ou um sal farmaceuticamente aceitável do mesmo e invenção
CN114875081A (zh) *	2022-06-07	2022-08-09	湖北迅达药业股份有限公司	一种瑞舒伐他汀关键中间体的绿色工业化生产方法
IL322082A (en)	2023-01-12	2025-09-01	Novartis Ag	Engineered ketoreductase polypeptides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5278313A (en) *	1992-03-27	1994-01-11	E. R. Squibb & Sons, Inc.	Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
GB9512837D0 (en)	1995-06-23	1995-08-23	Zeneca Ltd	reduction of ketone groups
CA2329893A1 (en) *	1998-04-30	1999-11-11	Kaneka Corporation	Process for producing 6-cyanomethyl-1,3-dioxane-4-acetic acid derivatives
ES2294236T3 (es)	1998-08-05	2008-04-01	Kaneka Corporation	Procedimiento para la preparacion de esteres sustituidos con 3,5-dihidroxi como intermedios para producir derivados de acido 2-(6-hiximetil)-1,3-dioxan-4-il) acetico opticamente activos.
DE19857302C2 (de)	1998-12-14	2000-10-26	Forschungszentrum Juelich Gmbh	Verfahren zur enantioselektiven Reduktion von 3,5-Dioxocarbonsäuren, deren Salze und Ester
EP1194582A1 (de)	1999-07-09	2002-04-10	Forschungszentrum Jülich Gmbh	Verfahren zur reduktion von keto-carbonsäuren und deren estern

2000
- 2000-11-24 CZ CZ20012792A patent/CZ20012792A3/cs unknown
- 2000-11-24 AT AT00977938T patent/ATE291616T1/de active
- 2000-11-24 US US09/890,821 patent/US6645746B1/en not_active Expired - Lifetime
- 2000-11-24 AU AU15517/01A patent/AU1551701A/en not_active Abandoned
- 2000-11-24 JP JP2001542518A patent/JP4510351B2/ja not_active Expired - Fee Related
- 2000-11-24 MX MXPA01007858A patent/MXPA01007858A/es active IP Right Grant
- 2000-11-24 SI SI200020017A patent/SI20642A/sl not_active IP Right Cessation
- 2000-11-24 CA CA002360376A patent/CA2360376C/en not_active Expired - Fee Related
- 2000-11-24 KR KR10-2001-7009856A patent/KR100512080B1/ko not_active Expired - Fee Related
- 2000-11-24 WO PCT/JP2000/008321 patent/WO2001040450A1/ja not_active Ceased
- 2000-11-24 DE DE60018909T patent/DE60018909T2/de not_active Expired - Lifetime
- 2000-11-24 HU HU0105331A patent/HUP0105331A3/hu unknown
- 2000-11-24 EP EP00977938A patent/EP1152054B1/en not_active Expired - Lifetime
- 2000-11-24 ES ES00977938T patent/ES2240205T3/es not_active Expired - Lifetime
2001
- 2001-08-02 NO NO20013801A patent/NO20013801L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP4510351B2 (ja)	2010-07-21
AU1551701A (en)	2001-06-12
KR20020008116A (ko)	2002-01-29
KR100512080B1 (ko)	2005-09-02
CZ20012792A3 (cs)	2002-03-13
CA2360376C (en)	2005-04-26
ATE291616T1 (de)	2005-04-15
DE60018909D1 (de)	2005-04-28
HUP0105331A2 (hu)	2002-05-29
EP1152054B1 (en)	2005-03-23
DE60018909T2 (de)	2006-03-30
ES2240205T3 (es)	2005-10-16
HUP0105331A3 (en)	2005-10-28
MXPA01007858A (es)	2003-07-14
NO20013801L (no)	2001-10-03
CA2360376A1 (en)	2001-06-07
EP1152054A1 (en)	2001-11-07
WO2001040450A1 (en)	2001-06-07
EP1152054A4 (en)	2002-11-20
US6645746B1 (en)	2003-11-11
NO20013801D0 (no)	2001-08-02

Publication	Publication Date	Title
SI20642A (sl)	2002-02-28	Nova karbonil-reduktaza, gen le-te in postopek za uporabo le-teh
KR100506134B1 (ko)	2005-08-08	신규한 카르보닐 환원효소 및 이것을 코딩하는 유전자 및 이러한 환원효소 및 유전자 이용방법
JPWO2001040450A1 (ja)	2003-06-03	新規カルボニル還元酵素、その遺伝子、およびその利用法
JP5261172B2 (ja)	2013-08-14	エリスロ又はスレオ−２−アミノ−３−ヒドロキシプロピオン酸エステルの製造方法、新規カルボニル還元酵素、その遺伝子、ベクター、形質転換体、およびそれらを利用した光学活性アルコールの製造方法
JP5516664B2 (ja)	2014-06-11	Ｎ−アセチル−（Ｒ，Ｓ）−β−アミノ酸アシラーゼ遺伝子
JP5761641B2 (ja)	2015-08-12	（ｒ）−３−キヌクリジノールの製造方法
JP3941998B2 (ja)	2007-07-11	コエンザイムｑ１０の製造法
JP2003502021A (ja)	2003-01-21	アスペルギルス起源のエポキシドヒドロラーゼ
JP4880859B2 (ja)	2012-02-22	新規カルボニル還元酵素、その遺伝子、およびその利用法
EP2128258B1 (en)	2013-09-11	Novel amidase, gene for the same, vector, transformant, and method for production of optically active carboxylic acid amide and optically active carboxylic acid by using any one of those items
JP5119783B2 (ja)	2013-01-16	Ｎ−アセチル−（Ｒ，Ｓ）−β−アミノ酸アシラーゼ遺伝子
JPWO2002010399A1 (ja)	2003-09-09	新規カルボニル還元酵素、その遺伝子、およびその利用法
JP6088973B2 (ja)	2017-03-01	新規アミダーゼ
EP1408107B1 (en)	2010-03-24	Chlorohydrin and hydroxycarboxylic ester asymmetric hydrolase gene
JP2006115729A (ja)	2006-05-11	光学活性β−ヒドロキシアミノ酸の晶析方法
JP3012908B2 (ja)	2000-02-28	ジヒドロ葉酸還元酵素―抗アレルギー性ペンタペプチド多量体の融合タンパク質（▲ｉ▼）
JP2002320491A (ja)	2002-11-05	新規なｄ−アミノアシラーゼをコードするｄｎａおよびそれを用いたｄ−アミノ酸の製造方法
JPWO2006043555A1 (ja)	2008-05-22	生体高分子生成のための還元酵素変異体
MXPA99007259A (en)	2000-04-24	Novel carbonyl reductase, gene that encodes the same, and method of utilizing these

Legal Events

Date	Code	Title	Description
2005-01-10	IF	Valid on the event date
2006-10-31	KO00	Lapse of patent	Effective date: 20060731